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Abstract 
The cell types that comprise neural networks are critical in determining their function. 
Within the globus pallidus externa (GPe), a nucleus of the basal ganglia implicated in 
Parkinsonism, several neuronal subpopulations have been described genetically and 
anatomically, but functional and physiological studies have been limited. This study examines 
the previously undescribed collateral connections between two key cell types in the GPe, defined 
by the genetic expression of parvalbumin (PV) or LIM homeobox 6 (Lhx6). Further investigation 
of this network in a mouse model of Parkinson’s Disease reveals a selective weakening of 
synaptic input from PV to Lhx6 neurons following dopamine lesions. This study builds on recent 
literature elucidating the roles of specific GPe cell types to basal ganglia function in health and 
disease. 
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1.0  INTRODUCTION 
1.1 BASAL GANGLIA 
The basal ganglia (BG) are a set of highly interconnected subcortical nuclei which, 
together, form a critical component of the motor structure within the central nervous system of 
vertebrates. The BG are central in a broad loop between the cortex and the thalamus, with 
information flowing from cortex, through the BG, and back to the cortex through the thalamus 
(Parent and Hazrati, 1995). These connections are thought to allow the BG to read and modify 
motor instructions before they are executed, participating in such processes as motor planning 
(Houk and Wise, 1995, Graybiel, 1998, Monchi et al., 2006) and action selection (Graybiel et al., 
1994, Redgrave et al., 1999). 
Several anatomically distinct nuclei comprise the BG, including the striatum, globus 
pallidus, subthalamic nucleus (STN), and substantia nigra. The globus pallidus and substantia 
nigra both can be further anatomically and functionally subdivided: the globus pallidus into the 
external (GPe) and internal (GPi) segments, and the substantia nigra into the pars compacta 
(SNc) and pars reticulata (SNr). Information in the BG is primarily received in the striatum and 
flows out through the GPi and SNr. The striatum projects to these output nuclei directly, but also 
projects to the GPe. Both the GPe and STN also innervate the BG output nuclei, in addition to 
being highly interconnected with one another.  
Classically, the BG have been divided into two functionally opposing branches, known as 
the “direct” and “indirect” pathways. These pathways arise from two distinct types of striatal 
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projection neurons, known as medium spiny neurons (MSNs), marked genetically by the type of 
dopamine receptors they express. MSNs that express D2-type dopamine receptors project to the 
GPe, forming the first component of the indirect pathway, whereas D1-expressing MSNs bypass 
the GPe and project directly to BG output nuclei, comprising the direct pathway (Smith et al., 
1998). Although both MSN types are GABAergic, and therefore inhibitory, the two pathways 
have opposing effects on BG output: D1-MSNs directly inhibit BG output nuclei, suppressing 
output, whereas D2-MSNs indirectly facilitate BG output by relieving the tonic inhibition of 
output nuclei by the GPe (Albin et al., 1989). Tonic inhibitory output from the GPi/SNr 
suppresses motor movements, serving as a kind of brake on motor activity (Deniau and 
Chevalier, 1985). Thus, the indirect pathway engages this brake, whereas the direct pathway 
relieves it. As such, dichotomous activation of one pathway or the other allows the BG to 
strongly influence which voluntary actions are carried out by an organism, and which are 
suppressed. 
1.2 PARKINSON’S DISEASE 
Parkinson’s Disease (PD) is a progressive, neurodegenerative disease of the BG that 
afflicts approximately five million people worldwide (Olanow et al., 2009). Its cardinal 
symptoms are motor deficiencies, including bradykinesia, resting tremor, rigidity, postural 
instability, and shuffling gait (Jankovic, 2008). These symptoms indicate a general paucity of 
movement, and become debilitating to PD patients. Because current PD treatments have limited 
effectiveness and associated risks (Cotzias et al., 1969, Merims and Giladi, 2008), new 
treatments could improve patients’ well-being. Since the BG is a primary brain area affected by 
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PD, a clearer understanding of how the normal role of the BG in movement is disrupted by PD 
could lead to new, and potentially more effective, treatment targets.  
1.2.1 Role of dopamine in the striatum 
PD is the result of the selective degeneration of dopamine (DA) neurons in the SNc, but 
the etiology is unclear. DA neurons of the SNc project broadly, targeting many areas of the 
brain, both within and outside of the BG (Guyenet and Aghajanian, 1978). However, among 
these numerous targets, DAergic innervation of the dorsal striatum is particularly dense 
(Descarries et al., 1996, Matsuda et al., 2009). As the dorsal region of the striatum is particularly 
involved in movement, loss of an important input to this area is a key factor in the development 
of motor symptoms in PD.  
DAergic input to the striatum differentially modulates the D1- and D2-MSNs that form 
the starting points for the direct and indirect pathways. Both receptor types are coupled with G-
proteins and have complex molecular interactions, but ultimately, their physiological effects 
oppose each other: D1 receptor activation enhances neuronal excitability, whereas D2 receptors 
diminish excitability (Neve et al., 2004). So, because striatal DAergic input serves to promote 
activity of the motor-enhacing direct pathway, and inhibits activity of the motor-suppressing 
indirect pathway, the overall effect of DA input to the striatum is pro-kinetic. As SNc neurons 
degenerate in PD, this pro-kinetic signal is lost. Under these conditions, the normal balance of 
activity between the direct and indirect pathways is disrupted. D1-MSNs are less active than in 
healthy conditions, and D2-MSNs are overactive (Albin et al., 1989, Mallet et al., 2006). The 
result is excessive BG output and suppression of movement, which is manifest in the motor 
symptoms of PD.  
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The resulting imbalance between the direct and indirect pathways that occurs after DA 
loss in PD is key to understanding the pathophysiology of the disease, but it is not the end of the 
story. DA replacement therapy, which restores the pro-kinetic signal to the striatum through 
drugs such as L-DOPA, is limited in its effectiveness due to adverse side effects, acquired drug 
resistance, and diminished potency as SNc neurons continue to degenerate (Cotzias et al., 1969, 
Merims and Giladi, 2008). Additionally, the effects of DA loss reach far beyond DA’s action on 
D1 and D2 receptors.  A slew of additional changes accompany chronic DA loss, altering the 
properties of the BG in ways that will be discussed in the following section. 
1.2.2 GPe contributions to PD pathophysiology 
Complex changes accompany the loss of DAergic input to MSNs, characteristically 
transforming the properties of the BG. Firing patterns become more irregular and/or bursty in 
several BG nuclei, including the GPe and GPi (Filion, 1979, Raz et al., 2000, Wichmann and 
Soares, 2006), STN (Levy et al., 2000, Wichmann and Soares, 2006), and SNr (Wichmann et al., 
1999).  Alongside these firing pattern changes is the aberrant intensification of oscillatory 
activity between 13-30 Hz, typically referred to as the β-frequency range (Hutchison et al., 1997, 
Hutchison et al., 1998, Brown et al., 2001). Although it is unclear that these oscillations are 
necessary for the development of motor deficits in PD, a correlation has been shown between the 
reduction of β-oscillations and the alleviation of PD symptoms during L-DOPA therapy (Kuhn et 
al., 2006). It has been suggested that the enhancement of this frequency range in the BG may 
occlude voluntary motor plans in favor of maintaining the current motor state, potentially 
explaining the difficulty in movement initiation seen in PD patients (Gilbertson et al., 2005, 
Engel and Fries, 2010, Little and Brown, 2014). Although amplified β-oscillations are found 
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throughout the Parkinsonian BG, their origin remains unknown.  However, the centrality of the 
GPe in the BG circuit makes it ideally suited for the transmission of pathological activity 
throughout (Smith et al., 1998, Mallet et al., 2008, Connelly et al., 2010). Indeed, a number of 
prominent changes of the GPe and its connections have been identified as potential contributors 
to mechanisms of aberrant BG function.  
Numerous studies suggest that aberrant GPe function contributes to PD pathophysiology 
in a variety of ways. A prominent hypothesis implicates recurrent GPe-STN connections in the 
facilitation of β-oscillations throughout the BG. The GPe-STN projection exerts powerful 
inhibitory control (Hallworth and Bevan, 2005, Baufreton et al., 2009), and becomes even more 
pronounced with the loss of DAergic neurons (Fan et al., 2012). After DA depletion, these 
reciprocally connected nuclei demonstrate reverberating, rhythmic activity in the β range, 
patterning each other’s behavior (Plenz and Kital, 1999, Mallet et al., 2008, Atherton et al., 2013, 
Nevado-Holgado et al., 2014). When this reverberation is interrupted by pharmacologically 
blocking GPe input to the STN, β-oscillations are reduced, and Parkinsonian symptoms improve 
(Bergman et al., 1990, Wichmann et al., 1994, Tachibana et al., 2011). Deep brain stimulation of 
both the GPe (Vitek et al., 2004) and STN (Benabid et al., 1994, Limousin et al., 1995) also 
alleviate motor deficits. More recently, reciprocal connections between the GPe and striatum 
have also been hypothesized to contribute to aberrant BG function, though a causal role of these 
connections in PD pathophysiology has yet to be demonstrated (Mallet et al., 2012, Corbit et al., 
2016, Glajch et al., 2016).   
In health, the desynchronized and regular firing patterns of GPe neurons (DeLong et al., 
1985, Nini et al., 1995) are shaped by their intrinsic properties, such as pace-making ability and 
lateral inhibition (Chan et al., 2004, Sadek et al., 2007, Goldberg et al., 2013, Wilson, 2013). 
 6 
Changes to such intrinsic properties have been implicated in the emergence of abberant 
oscillations and irregularity following DA loss. Downregulation of hyperpolarization-activated 
cyclic nucleotide-gated channel expression weakens the pace-making ability of GPe neurons, 
contributing to the irregular firing patterns seen in Parkinsonism (Chan et al., 2011). A decline in 
GABAA receptor subunit expression has also been shown to follow DA lesions (Caruncho et al., 
1997, Chadha et al., 2000). The lateral synaptic connections between GPe neurons may also play 
an important role in PD pathophysiology. Several computational studies have suggested that 
changes in this intrapallidal network could contribute to circuit-wide aberrant function in the BG 
(Terman et al., 2002, Goldberg et al., 2013, Wilson, 2013). It has been shown that synapses 
between GPe neurons are potentiated post-synaptically following DA lesions (Miguelez et al., 
2012), potentially upsetting the balance of inhibition in the nucleus. Unfortunately, despite the 
complex and heterogeneous nature of the GPe-GPe network (Sadek et al., 2007), tools to study 
these connections on a microcircuit level have not existed until recently. Just as distinct cell 
types within the striatum have a defining role in the function of the nucleus, recent studies show 
that the GPe has similar genetic and functional cellular diversity. Before contributions of the 
intrapallidal network to PD pathophysiology can be fully understood, the dynamics of distinct 
cell types within the nucleus must be examined. 
1.3 CELL TYPES OF THE GLOBUS PALLIDUS EXTERNA 
Although classic models of the BG envisage the GPe as a uniform, intermediate relay 
nucleus, evidence of diverse cell types has been observed since the earliest investigation of 
pallidal function. Functional evidence of distinct neuronal subpopulations has been shown 
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consistently in electrophysiological recordings of behaving animals, with data demonstrating that 
GPe neurons display heterologous firing patterns in response to movement (DeLong, 1971, 
Jaeger et al., 1995, Turner and Anderson, 1997, Benhamou et al., 2012). Dichotomous 
physiologically-defined neuron types have also been observed in recordings of tonic GPe 
activity, with most neurons firing at a rapid, regular rate, and a smaller subset of neurons 
showing sparse, irregular activity (Mallet et al., 2008, Mallet et al., 2012, Abdi et al., 2015). 
Anatomical evidence has corroborated the division of the GPe into (at least) two distinct 
neuronal subpopulations. Fast, regular-firing “prototypic” GPe neurons project downstream to 
the STN and SNr, whereas the slow, irregular-firing “arkypallidal” neurons selectively target the 
striatum (Mallet et al., 2012). The physiological distinctions between these two classes of 
neurons are enhanced by DA loss, indicating that they may have differential roles in PD 
pathophysiology (Mallet et al., 2008, Mallet et al., 2012).  
Many recent efforts have been made to establish genetic markers for GPe cell types, in 
order to better understand their functional differences, as well as to provide better tools to study 
them individually.  Within the GPe, arkypallidal neurons uniquely express preproenkephalin 
(Mallet et al., 2012) and forkhead box protein P2 (FoxP2), whereas prototypic neurons are 
thought to be marked by the expression of the transcription factors NK2 homeobox 1 (Nkx2-1) 
and LIM homeobox 6 (Lhx6), and derive from a separate embryonic lineage (Dodson et al., 
2015). Still further subdivisions of GPe cell types have been suggested, however. Genetic and 
anatomical studies have revealed that about 5% of GPe neurons express choline acetyltransferase 
exclusively of the markers proposed above (Mesulam et al., 1984, Rodrigo et al., 1998, 
Hernandez et al., 2015), and form a pathway between the GPe and frontal cortex whose role has 
yet to be thoroughly investigated (Saunders et al., 2015). Npas1 is also expressed by a minority 
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of GPe neurons, but since this population overlaps with markers of both prototypic and 
arkypallidal neurons, its usefulness as a label for a distinct class of GPe neurons is not yet clear 
(Hernandez et al., 2015). Finally, Mastro et. al 2014 provided evidence in adult transgenic mice 
that parvalbumin (PV) and Lhx6 mark functionally and anatomically distinct subclasses of 
prototypic GPe neurons. These two cell types differed in their intrinsic electrophysiological 
properties, and exhibited differential projection densities to areas both inside and outside of the 
BG, suggesting that they may serve distinct functional roles. 
As efforts to categorize the roles of genetically distinct GPe cell types are relatively new, 
any contribution they may have to PD pathophysiology has barely been examined. Data of cell-
type specific changes to GPe physiology are extremely limted. However, a study currently in 
review from our laboratory shows that differential modulation of PV and Lhx6-GPe neuron 
activity has a long-lasting pro-kinetic effect in a mouse model of PD (Mastro et al., 2016). When 
the GPe of bilaterally depleted mice were globally stimulated or inhibited, open-field motor 
activity did not change significantly. However, specific activation of PV-GPe (Fig. 1) and 
inhibition of Lhx6-GPe (Fig. 2) neurons both elicited robust and lengthy increases in motor 
behaviors. Though the mechanism for this effect is not clear, it is possible that the normal 
balance of activity between PV and Lhx6 neurons are shifted toward over-activation of Lhx6 
neurons in the disease state, and that the inhibition of Lhx6 neurons either directly, or through 
activation of PV-GPe collaterals, rescues kinetic behavior. In support of this hypothesis, in-vivo 
recordings during optical activation show that a population of putative non-PV neurons is 
inhibited during PV-GPe stimulation (Fig. 3). These results suggest not only that these two cell 
types have differential behavioral roles, but also identify their interaction as a promising 
therapeutic target for PD.  
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Figure 1. Selective stimulation of PV-GPe neurons rescues movement persistently in DA-
depleted mice. (a) Schematic of optogenetic stimulation of PV-ChR2. (b) Percentage of time 
spent in the immobile state before, during and after stimulation. (c) Overlay of immobility 
immediately before (pre), during (stim), and after (post), each light pulse. (d) Movement 
velocities, normalized by naïve controls, before and after stimulation. Bars denote population 
averages; connected circles show data for individual mice. 
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Figure 2.  Selective inhibition of Lhx6-GPe neurons rescues movement persistently in DA-
depleted mice. (a) Schematic of optogenetic inhibition of Lhx6-GPe neurons with 
archaerhodopsin. (b) Percentage of time spent in the immobile state before, during, and after 
inhibiton. (c) Overlay of immobility immediately before (pre), during (stim), and (post) each 
light pulse. (d) Movement velocities, normalized by naïve controls, before and after stimulation. 
Bars denote population averages; connected circles show data for individual mice.  
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Figure 3. Network Response during PV-ChR2 stimulation. (a) Schematic of GPe 
network during PV-ChR2 stimulation. (b) Light evoked responses of ten single units during 
onset of a 30 sec light pulse. ChR2
+
 denotes putative PV neurons, ChR2
-
 denotes putative 
non-PV neurons. (c) Average z-score of excited (red, n = 18) and inhibited (blue, n =14) 
neurons during a 30 sec light pulse. Shaded area denoted standard error of the mean. (d) 
Firing rates of individual neurons before, during (time 0) and in 10 ms bins after a 30 sec 
light pulse. Population averages are shown as thick, colored lines. 
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1.4 EXPERIMENTAL GOALS 
Microcircuits are critical in determining the overall function of nuclei, but given the 
novelty of genetically distinct GPe subpopulations, there has been little opportunity to examine 
intrapallidal circuit dynamics in a cell-type specific manner. Given the relevance of this network 
to BG function in health and disease, it is important to understand the individual contributions of 
specific cell types in both conditions. GPe-GPe synapses have previously been shown to be 
potentiated following DA lesions (Miguelez et al., 2012), but plasticity of distinct neuron types 
has not been examined. Changes in lateral inhibition between GPe neurons are thought to be 
relevant to PD pathophysiology (Goldberg et al., 2013, Schwab et al., 2013, Wilson, 2013), but 
whether these are global or specific has not been investigated. Our recent study using in-vivo 
optogenetics to modulate PV- and Lhx6-GPe neurons in a PD mouse model suggests that these 
two populations may be differentially affected by DA lesions. 
In this study, the previously undescribed collateral connections between PV- and Lhx6-
GPe are investigated. Using optogenetics with acute slice electrophysiology, the synaptic 
strength of the cell-type specific connections of both populations within the GPe are measured. 
Because no prior studies have examined the intrapallidal network in a cell-type specific manner, 
synaptic differences between the two neuronal subpopulations examined in this study were 
difficult to predict. However, based on a previous study showing a lower spontaneous firing rate 
of Lhx6 compared to PV-GPe neurons (Mastro et al., 2014), we reasoned that PV-Lhx6 synaptic 
connections may be more powerful than their reciprocal counterpart. Intrapallidal connections 
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are also examined in a mouse model of PD. Based on our previous behavioral results that the 
stimulation of PV-GPe and inhibition of Lhx6-GPe neurons are pro-kinetic following DA 
lesions, we believed a possible mechanism to be a shift in the relative dynamics of PV- and 
Lhx6-GPe activity toward over-activation of Lhx6-GPe neurons. Therefore, we hypothesized 
that intrapallidal inhibitory connections onto Lhx6 neurons are weakened after DA lesions. This 
study provides the first description of cell-type specific intrapallidal connections, and their 
potential role in PD pathophysiology.  
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2.0  MATERIALS AND METHODS 
2.1 ANIMALS 
Heterozygous mice on a C57BL/6J background were used for all experiments. Lhx6- and 
PV-GPe neurons were targeted for viral transfection using the Lhx6-iCre (Fogarty et al., 2007) or 
Pvalb-2A-Cre (Madisen et al., 2010) mouse lines. A subset of Pvalb-2A-Cre mice had also been 
crossed with an Lhx6-GFP mouse line (GENSAT, www.gensat.org) to allow for visualization of 
Lhx6-expressing neurons in these animals. Mice of both sexes were used in all groups. All 
experimental procedures were approved by the Carnegie Mellon University Institutional Animal 
Care & Use Committee, and are in accordance with the guidelines set forth by the National 
Institute of Health.  
2.2 SURGICAL PROCEDURES 
To achieve cell-specific expression of channelrhodopsin 2 (ChR2), the cre-dependent 
AAV2-DIO-ChR2-mCherry virus (University of North Carolina Vector Core Facility) was 
injected into the GPe of Lhx6-Cre, PV-Cre, or PV-Cre x Lhx6-GFP mice between the ages of 5-
7 weeks. A mixture of ketamine (50 mg/mL) and xylazine (15 mg/mL) was administered 
intraperitoneally to induce anesthesia. After being placed in stereotaxic frame (Kopf 
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Instruments), anesthesia was maintained with 1.5% isofluorane during the course of the surgery. 
The scalp was opened, and holes drilled bilaterally into the skull above the GPe (0.17 mm 
anterior, 2.12 mm lateral of Bregma). A Nanoject (Drummond Scientific) with a pulled glass 
pipette tip was lowered 3.60 mm from the surface of the brain, and 300-400 nL of virus was 
injected into the GPe over the course of 4-5 minutes. After the completion of the injection, the 
pipette was allowed to remain in the brain for another five minutes, in order to prevent backflow 
of the virus. Once bilateral injections of the GPe had been made, the scalp was sutured, and the 
mouse was removed from the stereotaxic frame. After it recovered from anesthesia, the mouse 
was then returned to its home cage, and housed for 2-3 weeks to allow for expression of the 
virus.  
A subset of animals were depleted of dopamine in a second surgery 11-18 days following 
their viral injection. These mice were anesthetized in the same way and placed on a stereotaxic 
frame. Holes were drilled bilaterally above the medial forebrain bundle (MFB, 0.45 mm 
posterior and 1.10 mm lateral of Bregma). A 33-guage cannula (Plastics One) was then 
positioned above the MFB, 5.10 mm below the surface of the brain. Five minutes after the 
cannula was positioned, 1μL of 6-hydroxydopamine (6OHDA, 5 μg/μL in 0.9% NaCl, Sigma) 
was injected at a rate of 0.2 μL/min. The cannula was then removed after five minutes. 
Following bilateral injections, the animal was sutured, and was returned to its home cage after 
recovery from anesthesia. To mitigate the deleterious health effects of bilateral dopamine 
depletion, special care was given to depleted animals. One half of their cage was placed on top of 
a heating pad, where it remained continually until the animal was sacrificed.  Trail mix and soft, 
wet food, which was replaced daily, was placed inside the cage. Additionally, depleted animals 
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received a daily intraperitoneal injection of saline (0.9% NaCl). They were also monitored 
closely for excessive weight loss and other signs of distress. 
2.3 ELECTROPHYSIOLOGICAL RECORDINGS 
To prepare acute brain slices for patch-clamp electrophysiological recordings, mice 
between the ages of 7-10 weeks were sacrificed at least two weeks after viral injections, and their 
brains were sectioned parasagittally at a thickness of 300 μm. Mice that had been DA-depleted 
were sacrificed three days after being injected with 6-OHDA. Slices were prepared using a Leica 
VT1000S vibratome. During the slicing procedure, brain tissue was kept in carbogenated, ice-
cold HEPES artificial cerebrospinal fluid consisting of the following (in mM): 20 HEPES, 92 
NaCL, 1.2 NaHCO3, 2.5 KCl, 10 MgSO4, 0.5 CaCl2, 30 NaH2PO4, 25 glucose, 5 sodium 
ascorbate, 2 thiourea, and 3 sodium pyruvate, at pH 7.3. Slices containing the GPe were 
transferred to a recovery solution at 33
o
C for fifteen minutes, which contained the following (in
mM): 93 N-methyl-D-glucamine, 2.5 KCl, 1.2 H2PO4, 30 NaHCO3, 20 HEPES, 25 glucose, 10 
MgSO4, 0.5 CaCl2, 5 sodium ascorbate, 2 thiourea, and 3 sodium pyruvate at pH 7.4. Following 
the recovery period, slices were transferred to a holding solution at room temperature and 
incubated for one hour before recording. The holding solution had the same components as the 
cutting solution, but contained 1 mM MgCl2 and 2mM CaCl2.  
During recordings, slices were held at 33
o
C in a bath of carbongenated artificial
cerebrospinal fluid containing the following (in mM): 125 NaCl, 26 NaHCO3, 1.25 NaH2PO4, 
2.5 KCl, 12.5 glucose, 1 MgCl2, and 2 CaCl2. Electrodes were made from borosilicate glass 
(pipette resistance, 2-6 MΩ) and filled with an internal solution containing the following (in 
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mM): 120 CsMeSO3, 15 CsCl, 8 NaCl, 0.5 EGTA, 10 HEPES, 2 Mg-ATP, 0.3 Na-GTP, 5 QX-
314. Physiological recordings were made from individual neurons in the whole-cell voltage 
clamp configuration. Data were gathered using a Multiclamp 700B amplifier (Molecular 
Devices) and an ITC-18 analog-to-digital board (HEKA) with Igor Pro software (Wavemetrics) 
and Recording Artist acquisition code (Richard C. Gerkin, Phoenix).  
2.4 IMMUNOHISTOCHEMISTRY 
At the conclusion of electrophysiological recording, slices were fixed with 4% 
paraformaldehyde in phosphate-buffered saline solution (PBS) for 18-24 hours, then transferred 
to 30% sucrose in PBS for an additional 24 hours. Slices were then re-sectioned to a thickness of 
30 μm prior to immunohistochemical processing. To stain for tyrosine hydroxylase (TH), re-
sectioned tissue was incubated for 24 hours with primary rabbit anti-tyrosine hydroxylase 
antibody (1:1000, Pel-Freez), then washed and incubated for 1.5 hours with Alexa-Fluor-647 
anti-rabbit (1:500, Invitrogen) secondary antibody.  To quantify remaining TH in DA-lesioned 
animals, epifluorescent images were taken bilaterally in dorsal striatum at 10x magnification. 
Using the pixel intensity measuring tool in ImageJ, pixel intensity over a 75 x 75 μm area was 
measured from both hemispheres. These data were normalized against the same measurements 
made from parallel-processed tissue gathered from healthy control animals.   
 18 
2.5 DATA ANALYSIS 
Analysis of evoked inhibitory post-synaptic currents (IPSCs) was carried out using Igor 
Pro software (Wavemetrics). Group data were tested for normality using the Shapiro-Wilk test in 
SPSS (IBM). Because several group datasets were not normally distributed, non-parametric tests 
were used for statistical comparisons. Comparisons between cell types within the same group of 
animals were made using the Wilcoxon Signed Rank Test for paired data (WSRT). Any 
comparisons between groups were made using the Mann-Whitney Wilcoxon (MWW) test. For 
all statistical tests, significance levels were set at α = 0.05. Throughout the text, data are reported 
as median ± standard deviation. 
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3.0  RESULTS 
To examine cell-type specific synapses between GPe neurons, inhibitory post-synaptic 
currents (IPSCs) were optically evoked with ChR2 and recorded from GPe neurons of various 
types. Cell-type dependent expression of ChR2 was achieved by bilateral stereotaxic injections 
of AAV2-DIO-ChR2-mCherry into the GPe of Lhx6-Cre, PV-Cre, or PV-Cre x Lhx6-GFP 
animals 2-3 weeks prior to electrophysiological recordings. Brain slices used for recording were 
obtained from healthy control animals and DA-depleted animals 3 days after bilateral 6-OHDA 
injections into the MFB. To control variability, each slice was checked for viral expression by 
imaging for ChR2-mCherry prior to recording (Fig. 4A). Data were not gathered from slices that 
did not exhibit viral expression throughout the GPe. After recording, slices were 
immunohistochemically stained for TH. For DA-depleted animals, electrophysiological data 
were only used from slices that had less than 20% TH remaining in the dorsal striatum compared 
to healthy controls (Fig. 4B and 4C). 
Voltage-clamp recordings were performed sequentially on neurons of heterogeneous 
types within 100 μm or each other. Cell types were primarily determined by ChR2 expression, 
which was tested by recording membrane currents at -80 mV while activating ChR2 with a 300 
ms pulse of blue light. Neurons that showed a sustained current response during the latter part of 
the stimulation (100-300 ms) were considered ChR2
+
, and assigned the cell type of PV or Lhx6 
appropriately according to the genotype of the animal.  Neurons that did not meet these criteria 
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Figure 4.  Histological verification of viral expression and TH immunoreactivity. (a) 
Epifluorescent image of viral expression in the GPe. Scale bar = 250 μm. (b) Representative 
images of striatal TH immunoreactivity in dorsal striatum of healthy control tissue (above) 
compared to a bilaterally depleted animal (below). Scale bar = 100 μm. (c) TH immunoreactivity, 
normalized to healthy controls, in bilaterally depleted PV-Cre and Lhx6-Cre animals. Bars denote 
population averages, dots denote data for individual animals. 
 Left                         Right       
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were considered non-PV or non-Lhx6. In PV-Cre x Lhx6-GFP animals, neurons that were both 
ChR2
-
 and GFP
+
 were considered to be Lhx6 neurons (Fig. 5B). 
IPSCs were recorded by evoking synaptic release with two 1 ms pulses of blue light 
100ms apart. Cells were held at the reversal potential for ChR2 (0 mV) preclude ChR2-mediated 
currents (Nagel et al., 2003). IPSCs evoked by stimulation of Lhx6 neurons did not show a 
statistical difference in amplitude (Fig. 6C, n = 15, WSRT, p = 0.39) between responses from 
Lhx6 (1960 ± 679 pA) and non-Lhx6 neurons (1773 ± 733 pA). Similarly, IPSCs evoked by 
stimulation of PV neurons did not show a statistical difference in amplitude (Fig. 5, n = 20, 
WSRT, p = 0.87) between PV (1385 ± 963 pA) and non-PV neurons (1743 ± 609 pA), nor was 
there a difference between responses of PV and proximate Lhx6 neurons (Fig. 5D; PV-PV: 1217 
± 552 pA, PV-Lhx6: 1538 ± 562 pA; n = 5, WSRT, p = 0.44). Additionally, PV-evoked (n = 40, 
1632 ± 795 pA) and Lhx6-evoked (n = 30, 1826 ± 714 pA) IPSC amplitudes were not 
significantly different (Fig. 7B, MWW, p = 0.43). These data suggest that there are no cell-type 
specific differences in the synaptic strength of intrapallidal collaterals in healthy mice. These 
results are not consistent with our hypothesis that Lhx6-GPe neurons receive stronger 
intrapallidal inhibitory input than PV-GPe neurons. 
Results from DA-depleted tissue indicate that intrapallidal synaptic transmission had 
been altered in a cell-type specific manner relative to control conditions. When PV-GPe neurons 
were stimulated in DA-lesioned tissue, IPSCs in PV neurons (1345 ± 698 pA) and non-PV 
neurons (548 ± 415 pA) differed significantly (Fig. 5D, n = 34, WSRT, p < 10
-7
). This difference 
held when comparing to the subset of non-PV neurons that were identified as Lhx6 (PV-PV: 
1389 ± 788 pA, PV-Lhx6: 425 ± 475 pA; n = 21, WSRT, p < 10
-5
). On the other hand, IPSCs 
evoked by Lhx6-GPe stimulation did not differ significantly (Fig. 6C, n = 18, MWW, p = 0.55)  
 22 
  
Figure 5.  IPSCs in the GPe evoked by PV-GPe optogenetic stimulation. (a) Schematic of 
voltage clamp recordings in the GPe. PV-GPe terminals in the field of view were optogenetically 
stimulated while IPSCs were sequentially recorded in proximate PV (orange) and Lhx6 (green) or 
otherwise non-PV (not pictured) neurons. (b) Example current traces of ChR2
+
 (orange) and 
ChR2
-
 (green) neurons in response to 300 ms light pulse (blue bar). Scale bars denote 500 pA 
(vertical) and 100 ms (horizontal). (c) Example current traces of PV (orange) and Lhx6 (green) 
neurons in response to 1 ms light pulses (blue bars) in DA-depleted tissue. Scale bar denotes 500 
pA (vertical) and 100 ms (horizontal). (d) Maximal IPSCs evoked by PV-GPe stimulation. 
Connected dots denote responses from proximate pairs of PV and non-PV neurons. Green pairs 
denote responses in which the non-PV neurons was identified as Lhx6
+
. Asterisks indicate 
significance. (e) PPR of evoked IPSCs. Dots denote data for individual neurons; bars denote 
population medians. Asterisks indicate significance. 
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Figure 6. IPSCs in the GPe evoked by Lhx6-GPe optogenetic stimulation. (a) Schematic of 
voltage clamp recordings in the GPe. Lhx6-GPe terminals in the field of view were optogenetically 
stimulated while IPSCs were sequentially recorded in proximate Lhx6 (blue) and non-Lhx6 (gray) 
neurons. (b) Example current traces of PV (orange) and Lhx6 (green) neurons in response to 1 ms 
light pulses (blue bars) in DA-depleted tissue. Scale bar denotes 500 pA (vertical) and 100 ms 
(horizontal). (d) Maximal IPSCs evoked by Lhx6-GPe stimulation. Connected dots denote responses 
from proximate pairs of Lhx6 and non-Lhx6 neurons.  
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between Lhx6 (1661 ± 1150 pA) and non-Lhx6 neurons (1613 ± 675 pA). Furthermore, the 
decrease in IPSC amplitude observed in non-PV neurons was found to be statistically significant 
when compared to control conditions (Fig. 5D, MWW, p < 10
-7
), which again held for PV-Lhx6 
synaptic responses (MWW, p < 10
-6
). Other synaptic responses were unchanged by DA-
depletion, however. PV-PV IPSCs were similar in control and DA-depleted tissue (Fig. 7B, 
WSRT, p = 0.83), as were overall IPSC responses to Lhx6-stimulation (DA-depleted: n = 36, 
1613 ± 938 pA; MWW, p = 0.97). These data suggest that, following DA loss, synaptic input 
from PV- to Lhx6-GPe neurons are weakened, while other intrapallidal connections among these 
neuron types remain unchanged. This result supports our hypothesis that intrapallidal inhibitory 
connections onto Lhx6 neurons are weakened after DA lesions.  
To examine the mechanism for the decrease in PV-nonPV IPSC amplitude seen in DA-
depleted animals, the paired-pulse ratio (PPR) of evoked IPSC amplitudes were compared across 
cell types and conditions. In control tissue, the PPR of responses in PV (0.61 ± 0.17) and non-PV 
(0.57 ± 0.18) did not differ significantly (Fig. 5E, MWW, p = 0.60). PPR was lower in both cell 
types in DA-lesioned tissue (PV: 0.50 ± 0.24, non-PV: 0.45 ± 0.20), but this decrease was only 
significant in non-PV neurons (Fig. 5E, MWW, PV: p = 0.15; non-PV: p = 0.02). These results 
do not explain the weakened response to PV stimulation seen in non-PV neurons following DA 
lesions. Typically, a decrease in PPR reflects an enhanced probability of synaptic release, a 
mechanism of synaptic potentiation (Schulz et al., 1994). The fact that decreased PPR 
accompanies the depressed responses seen at PV-nonPV synapses in DA-lesioned tissue suggests 
that other mechanisms of synaptic depression are responsible for the decreased IPSC amplitudes. 
Further study will be necessary to understand the mechanism of the plasticity demonstrated in 
these experiments. 
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In summary, our data show that while intrapallidal synaptic connections are similar 
across cell types in healthy conditions, PV input to Lhx6 neurons is selectively weakened after  
DA loss. These results support our hypothesis that intrapallidal inhibitory input to Lhx6 neurons 
is weakened in after DA lesions. Examination of the PPR at these synapses suggests that synaptic 
release probability may be enhanced, which does not explain the decrease in response amplitude. 
Further study will necessary to understand the mechanism of the plasticity demonstrated here, as 
well as its role in PD pathophysiology.  
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Figure 7. Summary of intrapallidal synaptic connections in healthy and DA-depleted tissue. (a) 
Schematic of intrapallidal synaptic connections. In health (left), lateral inhibition between PV and 
Lhx6 neurons is homogeneous. After DA-depletion (right), PV-Lhx6 input is selectively decreased. 
(b) Population data for maximal IPSCs across all conditions. Columns denote population medians. 
Error bars indicate standard deviation. Asterisks indicate significance.  
Healthy 
DA-
depleted 
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4.0  DISCUSSION 
This study provides the first characterization of intrapallidal synaptic transmission 
between two neuronal subpopulations of the GPe. Using the transgenic mouse lines PV-Cre and 
Lhx6-Cre, each population was independently stimulated with the use of optogenetics. This 
study revealed that while the connections between and within these two cell populations were 
essentially homogeneous in health, synaptic input from PV to Lhx6 neurons was selectively 
weakened in a mouse model of PD. These results reveal a putative cell-type specific contribution 
of the GPe to PD pathophysiology, and, with a further study, a new potential therapeutic target.  
The decreased synaptic input from PV to Lhx6 neurons after DA loss were consistent 
with our hypothesis that intrapallidal inhibition onto Lhx6 neurons is weakened following DA 
depletion. This hypothesis was based on our previous study of the effects of in-vivo optogenetic 
stimulation of these same GPe cell types, which revealed that stimulation of PV neurons and 
inhibition of Lhx6 neurons both produced long-lasting pro-kinetic effects in the same mouse 
model of PD employed in the present study. Taken together, the results of these two studies 
suggest that in PD, Lhx6-GPe neurons receive insufficient intrapallidal inhibitory input, and 
restoring that inhibition, either directly or indirectly through PV collaterals, has a therapeutic 
effect on Parkinsonian motor symptoms. There are a few caveats to this interpretation, however. 
First, such a conclusion ignores input to the GPe from other sources, as well as differential 
output of these two cell types, which may also contribute to the therapeutic effect seen in our in-
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vivo study. These factors will need to be investigated further. Next, while in the double 
transgenic PV-Cre x Lhx6-GFP mouse line, the PV and Lhx6 neuronal populations in the GPe 
barely overlap (Mastro et al., 2014), our more recent study shows that the PV-Cre and Lhx6-Cre 
populations overlap substantially (Mastro et al., 2016), in concurrence with other genetic studies 
of GPe subpopulations (Dodson et al., 2015, Hernandez et al., 2015). While these populations 
may not be mutually exclusive, they do not overlap entirely, and our differential synaptic and 
behavioral results strongly suggest that we are optically stimulating divergent cell populations. In 
future studies, alternative genetic tools, such as the PV-Flp mouse line (Madisen et al., 2015), 
may allow more selective optogenetic manipulation of these two cell populations. 
Previous studies of intrapallidal synaptic transmission are limited. Our results differ from 
another study of intrapallidal synapses, which showed that IPSCs evoked by global GPe 
stimulation were potentiated, rather than depressed, by chronic DA-depletion. Numerous 
methodological differences may have contributed to this discrepancy. In the present study, DA-
depletions were bilateral, and carried out 3 days prior to recording. We used this Parkinsonian 
model specifically so that we could examine the state of the GPe under same conditions as our 
previous study of in-vivo optogenetic modulation of GPe cell types. This is a notable difference 
from Miguelez et al. 2012, in which depletions were unilateral, and executed 2-3 weeks before 
recording; a much more chronic depletion by comparison. This difference in time course is the 
most likely reason for the differing conclusions between the studies; mechanisms of synaptic 
plasticity and compensation can operate on a timeline that exceeds 3 days. Because Miguelez et 
al. 2012 employed global GPe stimulation, rather than cell-type specific stimulation, it is not 
entirely certain that our results are wholly contradictory. To test this, our study would have to be 
repeated using a similar DA-depletion paradigm. It is possible, for instance, that PV-Lhx6 
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synapses are still weakened 2-3 weeks after DA-lesions, but other intrapallidal synapses are 
strengthened. Such a result would be masked by the global GPe stimulation utilized in Miguelez 
et al. 2012. For the moment, it is not possible for us to test whether the global nature of DA-
depletion paradigm directly contributed to the difference between these studies. Our acute 
bilateral depletions were limited to 3 days because this procedure had severe deleterious effects 
on the health of the animal. It would be extremely unlike for a mouse acutely, bilaterally 
depleted in the manner described in this study to survive for 2 weeks. However, in the future, 
gradual DA-depletion models, such as the one described in (Willard et al., 2015), may obviate 
this problem after further characterization.  
The mechanism for the altered transmission at PV-Lhx6 synapses remains unclear. 
Comparison of PPR data at this synapse between healthy and DA-depleted conditions suggested 
that presynaptic release probability was enhanced, rather than diminished, after DA-lesions. 
However, such a conclusion may not be entirely reliable. Previous studies have shown that 
stimulation of AAV2-ChR2 evoke artificially depressed responses compared to electrical 
stimulation at some synapses, though not all (Zhang and Oertner, 2007, Jackman et al., 2014). 
Alternate viral vectors for ChR2 have yielded improvement in this area, however (Jackman et al., 
2014), so these may be useful in future cell-type specific studies of intrapallidal synapses. Of 
course, other mechanisms of plasticity may be at play at the PV-Lhx6 synapse. Previous studies 
of gene expression in the GPe have shown a downregulation of GABAA-receptor subunits 
following DA lesions (Caruncho et al., 1997, Chadha et al., 2000). It is not clear that these 
receptors are downregulated specifically at intrapallidal synapses, but since striato-pallidal 
synaptic transmission is unchanged by DA-depletion (Miguelez et al., 2012), this would be a 
likely explanation. Furthermore, this downregulation of inhibitory receptors has been shown to 
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occur on a time course similar to the depletion paradigm used in this study (Caruncho et al., 
1997). Examining cell-type specific expression of GABAA receptors in the GPe of DA-intact and 
depleted tissue might enable a firmer conclusion regarding the mechanism of plasticity at PV-
Lhx6 synapses in the GPe. Other electrophysiological experiments, such as recording 
asynchronous synaptic release with the use of strontium, or measuring miniature IPSCs, would 
also be useful in assessing potential mechanisms of synaptic plasticity. 
Numerous aspects of the GPe microcircuit have yet to be characterized. In health, PV and 
Lhx6-GPe neurons have differential intrinsic properties, including input resistance, capacitance, 
and spontaneous firing rate (Mastro et al., 2014), but the properties of these cell types have not 
been investigated in DA-depleted animals. GPe subpopulations have also been posited to 
differentially innervate targets both within and outside the BG (Bevan et al., 1998, Mastro et al., 
2014, Saunders et al., 2015, Glajch et al., 2016). These projections have not been fully 
characterized in health, and have barely been examined in PD models. Innervation of the GPe by 
striatum and STN has also yet to be studied in a cell-type specific manner. These gaps in 
knowledge provide a multitude of future directions for investigations of the role of GPe 
subpopulations in PD pathophysiology.  
In conclusion, this study provides the first cell-type specific characterization of lateral 
inhibition within the GPe, and demonstrates an alteration of synaptic input onto a particular 
neuronal subpopulation within the GPe in a mouse model of PD. These results may reveal an 
important aspect of the mechanism by which aberrant GPe activity arises in PD, and contributes 
to its pathophysiology. Considered along with data from another recent study in which GPe cell 
types were optogenetically modulated in-vivo in the same PD model (Mastro et al., 2016), the 
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results of the present study suggest that the synaptic alteration shown herein can be successfully 
targeted to alleviate Parkinsonian motor deficits.  
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